CatalYm

CatalYm GmbH is a clinical-stage biotechnology company based in Planegg-Martinsried near Munich, Germany, developing next-generation cancer immunotherapies. Its lead approach neutralizes GDF-15 (Growth Differentiation Factor 15) to reverse a key immune-resistance mechanism in solid tumors, aiming to reinstate anti-tumor immune activity and overcome resistance to checkpoint-inhibitor and other cancer therapies. The company is a portfolio company of Canaan Partners. This is a biotech/pharmaceutical organization with no public developer API, SDK, or documentation surface; it is tracked in the API Evangelist network as a company profile rather than an API provider.

CatalYm is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Immunotherapy, and Oncology.

🌐 Visit website 📡 Source on GitHub

8.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsImmunotherapyOncologyCancerDrug DevelopmentGermany

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 8.9/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/catalym: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

LinkedIn

Other 1

Properties that don't map to a standard resource type

Imprint

Imprint

Source (apis.yml)

aid: catalym
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/catalym.png
name: CatalYm
description: CatalYm GmbH is a clinical-stage biotechnology company based in Planegg-Martinsried near Munich, Germany, developing
  next-generation cancer immunotherapies. Its lead approach neutralizes GDF-15 (Growth Differentiation Factor 15) to reverse
  a key immune-resistance mechanism in solid tumors, aiming to reinstate anti-tumor immune activity and overcome resistance
  to checkpoint-inhibitor and other cancer therapies. The company is a portfolio company of Canaan Partners. This is a biotech/pharmaceutical
  organization with no public developer API, SDK, or documentation surface; it is tracked in the API Evangelist network as
  a company profile rather than an API provider.
url: https://raw.githubusercontent.com/api-evangelist/catalym/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-industry: biotechnology
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Immunotherapy
- Oncology
- Cancer
- Drug Development
- Germany
apis: []
common:
- type: Website
  url: https://www.catalym.com/
- type: PrivacyPolicy
  url: https://www.catalym.com/privacy-policy/
- type: Imprint
  url: https://www.catalym.com/imprint/
- type: LinkedIn
  url: https://www.linkedin.com/company/catalym/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence